Ensitrelvir Shows Promise Preventing COVID-19 Post Exposure This post was originally published on Medscape You will shortly be re-directed to the publisher's website Daily oral drug reduced COVID-19 risk by 67% in exposed but uninfected adults Medscape Medical News